Quest Diagnostics (DGX) PT Raised to $185 at Mizuho Securities
Tweet Send to a Friend
Mizuho Securities analyst Ann Hynes raised the price target on Quest Diagnostics (NYSE: DGX) to $185.00 (from $166.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
